| Date | Time | Source | Headline | Symbol | Company |
| 05/06/2015 | 3:28AM | Analyst Ratings Network | Sarepta Therapeutics Upgraded to Outperform at Robert W. Baird (AVII) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/12/2012 | 8:20AM | Marketwired | Booming Biotechnology Industry Continues to Impress Investors in 2012 | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/12/2012 | 6:50AM | Marketwired | AVI BioPharma Announces Corporate Name Change to Sarepta Therapeutics and Stock Ticker Symbol Change to "SRPT" Effective Today | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/11/2012 | 6:04AM | Edgar (US Regulatory) | Amended Statement of Ownership (SC 13G/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 07/06/2012 | 4:05PM | Marketwired | AVI BioPharma to Present Company Overview at the Seventh Annual JMP Securities Healthcare Conference | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 06/13/2012 | 6:03AM | Edgar (US Regulatory) | Proxy Statement (definitive) (DEF 14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 06/05/2012 | 4:08PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 06/01/2012 | 5:28PM | Edgar (US Regulatory) | Proxy Statement - Notice of Shareholders Meeting (preliminary) (PRE 14A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 06/01/2012 | 4:30PM | Marketwired | AVI BioPharma Receives NASDAQ Notice of Minimum Bid Price Non-Compliance | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/11/2012 | 9:59AM | Marketwired | Potential Breakout Stock to Watch for 05/11/12: AVVC Issues News Release | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/10/2012 | 4:14PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/10/2012 | 4:05PM | Marketwired | AVI BioPharma Announces First Quarter 2012 Financial Results and Recent Corporate Developments | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/10/2012 | 9:04AM | Edgar (US Regulatory) | Quarterly Report (10-Q) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/04/2012 | 8:20AM | Marketwired | U.S Patent System to Transform From "First to Invent" to "First to File" - AVI BioPharma and XOMA Look to Benefit | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/04/2012 | 4:14AM | Zacks | Zacks #1 Rank Additions for Friday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/03/2012 | 8:30AM | Marketwired | AVI BioPharma Announces First Quarter 2012 Financial Results and Corporate Update Conference Call | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 05/02/2012 | 4:14AM | Zacks | Zacks #1 Rank Additions for Wednesday - Tale of the Tape | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/30/2012 | 4:34PM | Edgar (US Regulatory) | Amended Annual Report (10-K/A) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/25/2012 | 5:26PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/25/2012 | 5:25PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/25/2012 | 5:21PM | Edgar (US Regulatory) | Statement of Changes in Beneficial Ownership (4) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/25/2012 | 5:05PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/25/2012 | 8:30AM | Marketwired | AVI BioPharma to Present Additional Data From the Phase IIb Study of Eteplirsen for the Treatment of Duchenne Muscular Dystro... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/20/2012 | 10:10AM | Edgar (US Regulatory) | Confidential Treatment Order (CT ORDER) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/12/2012 | 4:33PM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/02/2012 | 9:12AM | Dow Jones News | US STOCK FUTURES: HOT STOCKS TO WATCH | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/02/2012 | 8:07AM | Edgar (US Regulatory) | Current report filing (8-K) | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 04/02/2012 | 7:00AM | Marketwired | AVI BioPharma Announces Eteplirsen Meets Primary Endpoint, Demonstrating a Significant Increase in Dystrophin at 24 Weeks Com... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/30/2012 | 8:00PM | Marketwired | AVI BioPharma Announces Conference Call and Webcast on Monday, April 2, 2012, to Discuss Top-Line Data Results From the Phase... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |
| 03/30/2012 | 8:30AM | Marketwired | Data From AVI BioPharma's Infectious Disease Programs to Be Presented at the 22nd European Congress of Clinical Microbiology ... | NASDAQ:AVII | Sarepta Therapeutics, Inc. (MM) |